Anne-Marie Beausoleil

Person

Redwood City, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating neurological disorders
- Patent number 11,993,580
- Issue date May 28, 2024
- NEUMORA THERAPEUTICS, INC.
- Paul Dransfield
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for modulating Interleukin-2-inducible T-cell...
- Patent number 11,897,874
- Issue date Feb 13, 2024
- CORVUS PHARMACEUTICALS, INC.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,718,616
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 11,642,332
- Issue date May 9, 2023
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Compounds and methods for modulating Bruton's Tyrosine Kinase
- Patent number 11,306,099
- Issue date Apr 19, 2022
- Angel Pharmaceutical Co., Ltd.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,299,492
- Issue date Apr 12, 2022
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine compounds as JAK kinase inhibitors
- Patent number 11,110,095
- Issue date Sep 7, 2021
- Theravance Biopharma R&D IP, LLC
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 11,033,533
- Issue date Jun 15, 2021
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Compounds and methods for modulating interleukin-2-inducible t-cell...
- Patent number 11,008,314
- Issue date May 18, 2021
- CORVUS PHARMACEUTICALS, INC.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acyl sulfonamides that are Bcl family antagonists for use in clinic...
- Patent number 10,981,892
- Issue date Apr 20, 2021
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for modulating bruton's tyrosine kinase
- Patent number 10,870,652
- Issue date Dec 22, 2020
- CORVUS PHARMACEUTICALS, INC.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phospholidines that are Bcl family antagonists for use in clinical...
- Patent number 10,745,429
- Issue date Aug 18, 2020
- UNITY BIOTECHNOLOGY, INC.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phosphonamidates that are Bcl family antagonists for use in clinica...
- Patent number 10,738,042
- Issue date Aug 11, 2020
- UNITY BIOTECHNOLOGY, INC.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acyl sulfonamides that are Bcl family antagonists for use in clinic...
- Patent number 10,717,722
- Issue date Jul 21, 2020
- UNITY BIOTECHNOLOGY, INC.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acyl phosphonamidates and acyl benzylamines that are Bcl family ant...
- Patent number 10,703,745
- Issue date Jul 7, 2020
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide-based proteasome inhibitors for treating conditions mediate...
- Patent number 10,689,416
- Issue date Jun 23, 2020
- Unity Biotechnology, Inc.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 10,548,879
- Issue date Feb 4, 2020
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,526,330
- Issue date Jan 7, 2020
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptide-based proteasome inhibitors for treating conditions mediate...
- Patent number 10,519,197
- Issue date Dec 31, 2019
- UNITY BIOTECHNOLOGY, INC.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 10,172,834
- Issue date Jan 8, 2019
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,100,049
- Issue date Oct 16, 2018
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine compounds as JAK kinase inhibitors
- Patent number 10,028,960
- Issue date Jul 24, 2018
- Theravance Biopharma R&D IP, LLC
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 10,005,740
- Issue date Jun 26, 2018
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 9,872,855
- Issue date Jan 23, 2018
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...
- Patent number 9,868,698
- Issue date Jan 16, 2018
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridines as JAK kinase inhibitors
- Patent number 9,725,470
- Issue date Aug 8, 2017
- Theravance Biopharma R&D IP, LLC
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...
- Patent number 9,670,143
- Issue date Jun 6, 2017
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 9,533,962
- Issue date Jan 3, 2017
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...
- Patent number 9,433,598
- Issue date Sep 6, 2016
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...
- Publication number 20240383884
- Publication date Nov 21, 2024
- Corvus Pharmaceuticals, Inc.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING NEUROLOGICAL DISORDERS
- Publication number 20240294492
- Publication date Sep 5, 2024
- Neumora Therapeutics, Inc.
- Paul Dransfield
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING NEUROLOGICAL DISORDERS
- Publication number 20240246928
- Publication date Jul 25, 2024
- NEUMORA THERAPEUTICS, INC.
- Paul Dransfield
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20240132520
- Publication date Apr 25, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF NLRP3 INFLAMMASOME AND RELATED PRODUCTS AND METHODS
- Publication number 20230365534
- Publication date Nov 16, 2023
- Neumora Therapeutics, Inc.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...
- Publication number 20220363676
- Publication date Nov 17, 2022
- Corvus Pharmaceuticals, Inc.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20220306624
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...
- Publication number 20220017485
- Publication date Jan 20, 2022
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20210401808
- Publication date Dec 30, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Killing Senescent Cells And Treating Senescence-Associated Conditio...
- Publication number 20210379078
- Publication date Dec 9, 2021
- Unity Biotechnology, Inc.
- Pieter Bas Kwak
- G01 - MEASURING TESTING
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20210130351
- Publication date May 6, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Phospholidines that are Bcl Family Antagonists for Use in Clinical...
- Publication number 20210070788
- Publication date Mar 11, 2021
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Phosphonamidates that are BCL Family Antagonists for Use in Clinica...
- Publication number 20200399259
- Publication date Dec 24, 2020
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...
- Publication number 20200392105
- Publication date Dec 17, 2020
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways...
- Publication number 20200360386
- Publication date Nov 19, 2020
- Unity Biotechnology, Inc.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...
- Publication number 20200354336
- Publication date Nov 12, 2020
- Unity Biotechnology, Inc.
- Nick Vlahakis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...
- Publication number 20200317640
- Publication date Oct 8, 2020
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20200281900
- Publication date Sep 10, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Application
Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...
- Publication number 20200199103
- Publication date Jun 25, 2020
- Unity Biotechnology, Inc.
- Nick Vlahakis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20200046709
- Publication date Feb 13, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Peptide-based proteasome inhibitors for treating conditions mediate...
- Publication number 20200002378
- Publication date Jan 2, 2020
- Unity Biotechnology, Inc.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...
- Publication number 20190382371
- Publication date Dec 19, 2019
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...
- Publication number 20190375743
- Publication date Dec 12, 2019
- Corvus Pharmaceuticals, Inc.
- Ryan HUDSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Acyl Phosphonamidates and Acyl Benzylamines that are Bcl Family Ant...
- Publication number 20190367496
- Publication date Dec 5, 2019
- Unity Biotechnology
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Phosphonamidates that are Bcl Family Antagonists for Use in Clinica...
- Publication number 20190330199
- Publication date Oct 31, 2019
- Unity Biotechnology
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phospholidines that are Bcl Family Antagonists for Use in Clinical...
- Publication number 20190330250
- Publication date Oct 31, 2019
- Unity Biotechnology
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20190269659
- Publication date Sep 5, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Application
Peptide-based proteasome inhibitors for treating conditions mediate...
- Publication number 20190248837
- Publication date Aug 15, 2019
- Unity Biotechnology, Inc.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20190106420
- Publication date Apr 11, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING BRUTON'S TYROSINE KINASE
- Publication number 20190106423
- Publication date Apr 11, 2019
- Corvus Pharmaceuticals, Inc.
- Ryan HUDSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Anne-Marie Beausoleil

Person

Patents Grantslast 30 patents

Methods of treating neurological disorders

Compounds and methods for modulating Interleukin-2-inducible T-cell...

JAK kinase inhibitor compounds for treatment of respiratory disease

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Compounds and methods for modulating Bruton's Tyrosine Kinase

JAK kinase inhibitor compounds for treatment of respiratory disease

Pyrimidine compounds as JAK kinase inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Compounds and methods for modulating interleukin-2-inducible t-cell...

Acyl sulfonamides that are Bcl family antagonists for use in clinic...

Compounds and methods for modulating bruton's tyrosine kinase

Phospholidines that are Bcl family antagonists for use in clinical...

Phosphonamidates that are Bcl family antagonists for use in clinica...

Acyl sulfonamides that are Bcl family antagonists for use in clinic...

Acyl phosphonamidates and acyl benzylamines that are Bcl family ant...

Peptide-based proteasome inhibitors for treating conditions mediate...

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

JAK kinase inhibitor compounds for treatment of respiratory disease

Peptide-based proteasome inhibitors for treating conditions mediate...

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

JAK kinase inhibitor compounds for treatment of respiratory disease

Pyrimidine compounds as JAK kinase inhibitors

Neprilysin inhibitors

(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...

Substituted naphthyridines as JAK kinase inhibitors

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...

Patents Applicationslast 30 patents

COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...

METHODS OF TREATING NEUROLOGICAL DISORDERS

METHODS OF TREATING NEUROLOGICAL DISORDERS

NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS

MODULATORS OF NLRP3 INFLAMMASOME AND RELATED PRODUCTS AND METHODS

COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

Killing Senescent Cells And Treating Senescence-Associated Conditio...

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

Phospholidines that are Bcl Family Antagonists for Use in Clinical...

Phosphonamidates that are BCL Family Antagonists for Use in Clinica...

Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...

Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways...

Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...

Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...

PYRIMIDINE COMPOUNDS AS JAK KINASE INHIBITORS

Peptide-based proteasome inhibitors for treating conditions mediate...

Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...

COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL...

Acyl Phosphonamidates and Acyl Benzylamines that are Bcl Family Ant...

Phosphonamidates that are Bcl Family Antagonists for Use in Clinica...

Phospholidines that are Bcl Family Antagonists for Use in Clinical...

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

Peptide-based proteasome inhibitors for treating conditions mediate...

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

COMPOUNDS AND METHODS FOR MODULATING BRUTON'S TYROSINE KINASE